logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Parker Labs Leads Investment In Solstice Pharmaceuticals' Innovative Ultrasound Contrast Agent

Jul 07, 2021•over 4 years ago
Enschede

Description

Solstice Pharmaceuticals has successfully completed its latest round of funding to further the clinical development of its innovative ultrasound contrast agent (UCA). The first-of-its-kind contrast agent uses unique microbubble technology that dramatically enhances image contrast, improves diagnostic accuracy and makes ultrasound more widely applicable for a wide range of diagnostic and therapeutic applications.

Company Information

Company

Solstice Pharmaceuticals

Location

Enschede, Overijssel, Netherlands

About

Solstice Pharmaceuticals is a Dutch company dedicated to creating the next generation of diagnostic and therapeutic ultrasound products. They develop, manufacture and commercialize ultrasound contrast agents to support healthcare professionals in effectively and accurately diagnosing their patients. For more information, visit solsticepharma.com.